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An evaluation of the SureiD 
23comp Human Identification Kit 
for kinship testing
Hussain M. Alsafiah  1,2*, Ali A. Aljanabi1, Sibte Hadi  1, Saleh S. Alturayeif2 & 
William Goodwin  1*
Short tandem repeat (STR) profiling has been routinely used in kinship testing since the introduction 
of commercial kits in the mid-1990s. While 15 to 23 STR loci normally give definitive results in simple 
kinship testing, additional loci are sometimes required to resolve complex cases. The SureID 23comp 
Human Identification Kit, recently released by Health Gene Technologies (China), multiplexes 
amelogenin and 22 autosomal STRs, 17 of which are non-CODIS STRs. This enables the profiling 
of 38–40 loci when used in conjunction with widely used commercial kits. In this study, the kit was 
evaluated for kinship applications as a supplementary STR kit following the minimum criteria for 
validation recommended by the European Network of Forensic Science Institutes (ENFSI) and the 
Scientific Working Group on DNA Analysis Methods (SWGDAM) using 500 samples. Performance was 
comparable with other commercial kits demonstrating: repeatability and reproducibility; precision 
(maximum s.d. 0.1048 nt); accuracy, all alleles were within ±0.41 nt compared to the actual sizes; 
heterozygous peak balances at all loci >68%; stutter ratios ranged from 3.8% to 16.15%; full profiles 
were generated with 125 pg DNA (95.12% of alleles at 62 pg),; and we found 100% concordance over 5 
common STRs with the GlobalFiler kit.
The extended number of STR markers required for the Combined DNA Index System (CODIS) and for the 
European Standard Set (ESS)1,2, has led to the development of GlobalFiler PCR Amplification Kit, VeriFiler Plus 
PCR Amplification Kit (Applied Biosystems (AB), USA), PowerPlex Fusion 6 C System (Promega Corporation, 
USA) and Investigator 24plex (Qiagen, Germany). The information obtained from these kits will be sufficient in 
most kinship cases; however, it is still possible to have inconclusive results in complex cases3. Kinship testing can 
be further complicated when the level of consanguinity in the target population is relatively high4, or when the 
family pedigree is deficient5.
It has been demonstrated that additional STRs can increase the power of genetic testing in determining the 
true relationship  between parent-child, siblings or half siblings6. For example, Carboni et al.7 described four 
complex cases, including incest, which were inconclusive using 13–15 STRs, but that could be resolved using 
39–41 STRs.
As most loci are shared between the commonly used kits, the maximum number of STRs that can be tested 
when combining any two is 24 STRs (e. g. VeriFiler Plus and PowerPlex Fusion 6 C), which necessitates the use 
of a supplementary STR kit when more loci need to be tested. A set of 25 supplementary STRs was suggested by 
the National Institute of Standards and Technology (NIST) to increase the certainty in kinship testing8; how-
ever, no multiplex combing these STRs is commercially available. Supplementary Kits: Microreader 23sp ID9 
(Suzhou Microread Genetics, China), Goldeneye DNA ID 22NC10 (Goldeneye Technology Ltd., China), AGCU 
21 + 111 (AGCU ScienTech Incorporation, China) have been developed, but they are only commercially available 
in China12.
Massively parallel systems (MPS) allow simultaneous sequencing of multiple DNA makers. For example, 
Precision ID GlobalFiler NGS STR13 (20 CODIS STRs and nine non-CODIS STRs)(AB), Promega PowerSeq 
Auto/Y system14 (20 CODIS STRs, Penta D, Penta E, and 23 Y-STRs) (Promega Corporation), and ForenSeq DNA 
Signature Prep15 (20 CODIS STRs, seven non-CODIS STRs, 24 Y-STRs, 7X-STRs and 94 identity informative 
1School of Forensic and Applied Sciences, University of Central Lancashire, Preston, United Kingdom. 2Forensic 
Genetics Laboratory, General Administration of Criminal Evidences, Public Security, Ministry of Interior, Riyadh, 
Saudi Arabia. *email: hmhalsafiah@uclan.ac.uk; whgoodwin@uclan.ac.uk
open
2Scientific RepoRtS |         (2019) 9:16859  | https://doi.org/10.1038/s41598-019-52838-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
SNPs) (Verogen, USA). These can be utilised to increase the power of kinship testing15,16. However, the systems 
are expensive to establish and are not yet commonly used in many laboratories.
SureID 23 comp Human Identification Kit (Health Gene Technologies, China), combines amelogenin and 
22 autosomal STRs: D1S1656, D2S441, D10S1248, D12S391, D16S539 and 17 non-CODIS STRs (D3S1744, 
D4S2366, D5S2800, D6S474, D7S3048, D8S1132, D9S1122, D11S2368, D13S325, D14S1434, D15S659, 
D17S1301, D18S1346, D19S253, D20S482, D21S2055, and D22GATA198B05). Twelve of these STRs are not 
included in other supplementary kits, such as Investigator HDplex Kit17 (Qiagen) and PowerPlex CS7 System18 
(Promega Corporation) (Table 1). The kit is now available in the UK and Europe.
It is important to note that the D5S2800 locus was named as D5S2500 in the panels and in the supporting 
documents of the SureID 23comp Kit that may cause some confusion19 (Note S1).
Testing additional STRs increases the number of loci situated on the same chromosome (syntenic loci), 
but raises concerns regarding their independence during meiosis. Syntenic loci are regarded as independent 
(unlinked) if they are 50 centimorgans (cM) or more apart (at which point the probability of recombination 
between them is 0.5)20. As recombination rates vary along chromosomes, using the physical distance (per bp) 
may underestimate or overestimate the genetic distance between syntenic loci21. Therefore, family studies have 
been undertaken to estimate the recombination fraction (RF) between syntenic loci21–24. However, family studies 
are expensive and, sometimes, may not be informative enough due to the need of a large number of generations 
(meiosis) and high percentage of heterozygote genotypes4,22. An alternative approach employed by Phillips et al.4 
used the high-density multi-point SNP data of HapMap to approximate the genetic distance between syntenic loci 
to estimate the RFs, which showed RF values similar to those generated using the family studies.
The SureID 23 comp was used to generate population genetic data for three main populations European, 
South Asian and African25, but it is believed that the kit has not been validated as no publications currently exist, 
either independently or from the manufacturer. Therefore, this study aimed to evaluate the performance of the 
SureID 23comp Kit for kinship applications as a supplementary STR kit. The minimum criteria for validation 
recommended by the ENFSI and by the SWGDAM were followed; mixture studies were not included as the kit is 
specifically designed to be used in complex kinship testing. In addition, the 17 non-CODIS loci were evaluated 
using a population (500 individuals) from Saudi Arabia. The data of the 17 non-CODIS loci were merged with 
the data of 21 STRs generated from the same samples26, and were used for testing potential linkage between 
Chr.
SureID 23comp Investigator 
HDplex STRs(a,b)
PowerPlex CS7
STRsSTRs(a) Location (GRCh38) Repeat structure*
1 D1S1656a 230769616–230769683 CCTA [TCTA]n F13B
2 D2S441a 68011947–68011994 [TCTA]n D2S1360
3 D3S1744 147374752–147374828 [ATAG]n atg [ATAG]n at [ATAG]n D3S1744
4 D4S2366 6483114–6483172 [GATA]n [GATT]n [GATA]n gac [GATA]n D4S2366
5 D5S2800 59403132–59403199 [GGTA]n [GACA]n [GATA]n [GATT]n D5S2500
6 D6S474 112557951–112558018 [AGAT]n [GATA]n D6S474, SE33b F13A01
7 D7S3048 21227099–21227174 [TATC]n [TACC]n [CACC]n D7S1517
8 D8S1132 106316692–106316774 [TCTA]n tca [TCTA]n D8S1132 LPL
9 D9S1122 77073826–77073873 [TAGA]n Penta C
10 D10S1248a 129294244–129294295 [GGAA]n D10S2325
11 D11S2368 19259601–19259684 [TATC]n [TGTC]n [TATC]n
12 D12S391a 12297020–12297095 [AGAT]n [AGAC]n AGAT D12S391a
13 D13S325 42599304–42599382 [TCTA]n tca [TCTA]n
14 D14S1434 94842054–94842105 [CTGT]n [CTAT]n
15 D15S659 46081911–46081966 [TATC]n FESFPS, Penta E
16 D16S539a 86352702–86352745 [GATA]n
17 D17S1301 74684855–74684902 [AGAT]n
18 D18S1364 65732998–65733056 [TAGA]n TACA [TAGA]n D18S51a
19 D19S253 15617484–15617531 [ATCT]n
20 D20S482 4525692–4525747 [AGAT]n
21 D21S2055 39819508–39819649 [CTAT]n CTAA [CTAT]n (30n) [TATC]n D21S2055 Penta D
22 D22GATA198B05 17169811–17169882 CTCT [ATCT]n [ACCT]n
Table 1. STR Markers included in the SureID 23comp Kit. This table shows the locations (GRCh38) and 
repeat structures of the 22 STRs included in the SureID 23comp Kit. Five loci are common with the CODIS 
and the ESS. Twelve loci are not included in other available supplementary kits (Investigator HDplex and 
PowerPlex CS7). All information was adopted from17,18,39. As proposed by Phillips19, the D5S2500 locus name is 
corrected to D5S2800 (Please see Note S1). aCODIS and ESS locus. bGermany core locus. *Lowercase and italic 
nucleotides are not counted in allele nomenclature system39.
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syntenic loci (linkage disequilibrium, LD). RF values of syntenic pairs were reviewed from4,12,21,22,24, which were 
estimated using family studies and using HapMap data. RFs derived from HapMap data for D2S1338-D2S441, 
TPOX-D2S1338, FGA-D4S2366 and D5S2800-CSF1PO pairs, were calculated based on cumulative genetic map 
distance provided by Phillips12 and using the Excel tool developed by Phillips et al.4.
Methods
The study was performed in accordance with the ethical guidelines of the University of Central Lancashire 
(UK) and was approved by the Security Forces Hospitals Programme (SFHP, Saudi Arabia), the Medical Legal 
Directorate, Ministry of Health (MLD, Iraq) and by Ethics Committee of the University of Central Lancashire.
DNA samples. Initial tests of the SureID 23comp Kit were carried out using the 2800 M control DNA 
(Promega Corporation). The control DNA was also used for sensitivity and stochastic tests by preparing five 
serial dilutions of (500, 250, 125, 62, and 31) pg. In addition, 0.5 ng of the control were amplified with the pres-
ence of different concentrations (50, 75, 100, 120 and 150) ng/µl of common PCR inhibitors humic and tannic 
acids (Sigma-Aldrich, USA). The 9947 A control DNA provided with the kit was used with every run as a positive 
control.
The performance of the kit was further assessed using nine bone samples that were collected from a mass grave 
in Iraq after obtaining a permission from the MLD, Ministry of Health (Iraq). The bone samples were previously 
extracted using PrepFiler BTA Forensic DNA Extraction Kit (AB) and were quantified using Quantifiler Trio 
DNA Quantification Kit (AB). The concentrations of the small fragments of the Quantifiler Trio ranged from 
0.0173 ng/µl to 0.3271 ng/µl and the Degradation Indexes (DI) were from 1.6758 to 57.666 (Table S1). These sam-
ples were previously profiled using one or more of the commonly used STR kits (Table S1).
The study of precision, accuracy, peak balance, concordance and stutter peak ratios were carried out using 500 
samples from unrelated individuals from the population of Saudi Arabia. The samples were collected after obtain-
ing informed consents from all participants. The extraction and the quantification were described in a previous 
study that evaluated the 21 STR loci included in the GlobalFiler PCR Amplification Kit26.
Sample amplification. The Initial tests of the SureID 23comp used two reaction volumes that were opti-
mised by the manufacturer. A 25 µl volume that contained 12.5 µl master mix, 6.25 µl primer mix and up to 6.25 µl 
of DNA template; and a 10 µl volume that contained 5 µl master mix, 2.5 µl primer mix and up to 2.5 µl of DNA 
template. The range of recommended template DNA is 0.5–4 ng. To validate both volumes, two operators carried 
out the initial tests independently with 0.5 ng of control DNA in five replicates (20 tests in total).
Three DNA concentrations (0.5, 0.35, and 0.25) ng were used for the first 90 samples from the Saudi popu-
lation to evaluate the performance of the 10 µl volume. Then, the rest of samples (410 samples) were genotyped 
using the 10 µl volume with 0.5 ng DNA input per reaction.
Microamp Optical 96-Well Reaction Plates and Microamp Optical Adhesive Films (AB), were used for ampli-
fication; 2.5 µl of the DNA and DNase/RNase-free water were added to 7.5 µl of the SureID 23comp mix (5 µl 
master mix and 2.5 µl primer mix).
A Veriti thermal cycler (AB) was employed to carry out the amplification reactions as follows: [95 °C (5 min)]/
[94 °C (10 s) 61 °C (60 s) 70 °C (30 s)] 28–30 cycles/[60 °C (15 min)]. The 28 cycle protocol was used for the initial 
tests, stability tests and for the 500 samples. For sensitivity and stochastic study, the serial dilution samples were 
amplified in five replicates using both reaction volumes, each volume was tested with 28 and 30 PCR cycles (100 
tests in total). For the bone samples, the 25 µl volume and 30 PCR cycles were used.
DNA separation and analysis. An ABI 3500 DNA Genetic Analyser with 50 cm capillaries and POP-6 
polymer (AB) was used for the separation and detection. The spectral calibration mix was prepared by adding 
8 µl HGT 5-Dye Matrix Standard (Health Gene Technologies) to  200 µl of Hi-Di Formamide (AB); 10 µl were 
dispensed to each well. In the data collection software (AB), the dye set of SureID 23comp was created based on 
the G5 template as recommended by manufacturer.
Samples were prepared for separation and detection by adding 1 µl of PCR products or of an allelic ladder 
(Health Gene Technologies) to 9 µl of Hi-Di Formamide/Size-500-Plus Mix. This mix was prepared by 9 µl of 
Hi-Di Formamide (AB) and 0.25 µl Size-500-Plus (Health Gene Technologies), for each sample. Based on the 
manufacturer’s guidelines, the run time in the module HID36_POP4 should be 1,210–1,500 s when using a 36 cm 
capillary. In this study, the run time was increased to 3900 s to accommodate the use of the 50 cm capillaries.
Alleles from the 23 markers were called using GeneMapper ID-X Software v1.2 (AB) with an allelic ladder 
mix supported by panels and bins provided by the manufacturer. For the sensitivity and stability tests, the mini-
mum relative fluorescent units (RFU) was 50 RFU for heterozygous genotypes and was 150 RFU for homozygous 
genotypes.
Population study. PowerStat v 1.2 (Promega Corporation) was utilised to calculate allele frequencies, match 
probability, power of discrimination, power of exclusion, typical paternity index and polymorphic information 
contents. RStudio platform v1.2.133527 and DNA tools package v0.1-2228, were used to identify the maximum 
number of matched loci within the 500 samples. The Exact test for detecting deviation from the Hardy-Weinberg 
equilibrium (HWE) was carried out by Arlequin v3.5.2.1 Software29, using 1,000,000 steps for the Markov chain 
and 100,000 for the dememorization steps.
LD and RF study. The Arlequin v3.5.2.1 Software29 was also used to test LD between potentially 18 syntenic 
loci resulting from combining 38 loci available in GlobalFiler (21 STRs) and SureID 23comp (17 non-CODIS 
STRs) kits. This was carried out by applying 1000 in the permutations and 2 in the Expectation-Maximisation 
(EM) algorithm. RF values of syntenic pairs were reviewed from4,12,21,22,24, which were estimated using 
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family studies and using HapMap data. RFs derived from HapMap data for D2S1338-D2S441, TPOX-D2S1338, 
FGA-D4S2366 and D5S2800-CSF1PO pairs, were calculated based on cumulative genetic map distance provided 
by Phillips[12] and using the Excel tool developed by Phillips et al.4.
Results and Discussion
Evaluation of the SureID 23comp Kit. The first step in the validation was a confirmation of the identity of 
the D5 locus included in the multiplex by testing the 9947 A control DNA provided in the kit as a positive control 
(Note 1). The 9947 A control DNA showed alleles 14, 23 at the D5 locus confirming that the locus is D5S2800 and 
not D5S250019.
In the initial tests of the SureID 23comp, the replicates of the 2800 M control DNA, were successfully pro-
filed by two independent operators and 20 replicates were fully concordant confirming the repeatability and 
reproducibility.
Each of the dilution series samples was replicated five times using the 25 µl and 10 µl volumes with 28 and 30 
cycles (100 reactions in total). Full profiles were generated from the 125 pg samples when using the 10 µl volume 
(28 and 30 cycles), while 25 µl volume was able to generate a full profile with 30 PCR cycles only. For the 62 pg 
samples, the 28 cycle protocol allowed detection of 60.9% (25 µl) to 80.48% (10 µl) and the 30 cycle protocol 
allowed detection of 90.2% (25 µl) to 95.12% (10 µl) where the rest of the alleles were visible and could be detected 
with a reduced RFU threshold of 30. With 31pg, the profile percentage was from 53.6% (25 µl) to 85.3% (10 µl) 
using the 30 cycle protocol, while allele dropout was observed with 28 cycle protocol (Fig. 1). The sensitivity 
results are comparable to other commonly used kits, for example, Identifiler Kit30, Investigator HDplex Kit21 and 
PowerPlex Fusion 6 C System31 where the profile percentage ranged from 82% to 94% for the 62 pg and from 37% 
to 72% for the 31pg.
The performance of the SureID 23comp Kit with different concentrations of two common PCR inhibitors was 
tested. Full profiles were generated in the presence of ≤ 120 ng/µl of tannic acid and of ≤ 75 ng/µl of humic acid 
(Figs S1 and S2). Although these levels are similar to those reported for the SureID PanGlobal Kit (Health Gene 
Technologies)32, other commonly used kits are more robust in the presence of higher concentrations of inhibi-
tors33 (Fig. S3).
The sensitivity and the stability of the SureID 23comp were further evaluated using nine bone samples. The 
bone samples were profiled using the 25 µl volume to increase the volume of the DNA input in the PCRs to 
6.25 µl. Seven samples, where the total DNA input ranged from 0.2575 ng to 2.0444 ng/reaction, showed similar 
percentage of detected alleles to other kits previously used (Table S1). However, two samples that had lower con-
centrations and higher DIs of 0.0173 ng/µl (DI: 57.7) and 0.0194 ng/µl (DI: 16.2) (total DNA input 0.1081 ng and 
0.1213 ng), the performance deteriorated, both in absolute terms, and in comparison to other kits. It is notable 
that the capacity of DNA quantity in the other kits (15 µl) allowed 2.4 fold more DNA to be added to the reaction 
Figure 1. Sensitivity and stochastic tests for the SureID 23comp Kit. Serial dilutions (500, 250, 125, 62, and 31) 
pg were prepared from the 2800 M control DNA (Promega Corporation). Each test was done on five replicates 
and the sample with the highest number of detected alleles are shown. Each cell represents an allele and merged 
cells represent homozygote loci in the 2800 M. Green cells identify detected alleles with ≥60% peak balance 
ratios. Yellow cells identify detected alleles with <60% peak balance ratios. Red cells represent undetected alleles 
with threshold of 50 RFU/150 RFU for heterozygotes/homozygotes.
5Scientific RepoRtS |         (2019) 9:16859  | https://doi.org/10.1038/s41598-019-52838-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
compared to the SureID 23comp (6.25 µl). Overall, the sensitivity tests when using the DNA control, demon-
strated the robustness of generating full profiles even below the recommended DNA concentrations and showed 
similar sensitivity to other commonly used STR kits. However, this kit  demonstrated reduced sensitivity with the 
bone samples, which is most likely due to the limited capacity of DNA input compared to other kits (Table S2). 
Although this kit was designed as a supplementary kit for forensic genetics laboratories, some cases may involve 
human remains (e.g. disaster victim identification (DVI)). Therefore, increasing the concentrations of the master 
and primer mixes (e.g. to 2X) would permit additional space for more DNA input especially for highly degraded 
samples.
Peak balances evaluation started with measuring of the optimal DNA quantity for the 10 µl volume using 
the first 90 samples that were tested using three different DNA quantities (0.5, 0.35, and 0.25) ng. With all tem-
plate amounts the minimum peak balance ratios were >68%, which meets the criteria set out in the ENFSI 
guidelines (>60%). The DNA input of 0.5 ng achieved the most balanced heterozygous peaks with an average 
of 88.31% (Table S3), the values were which are similar to ratios observed when testing other kits, for example 
Investigator HDplex Kit21. The D21S2055 showed the lowest degree of balance at all template concentrations 
with ratios of 73.11% at 0.5 ng, 79.75% at 0.35 ng and 68.12% at 0.25 ng (Table S3). The remaining 410 samples 
were successfully profiled using the 10 µl volume and 0.5 ng of DNA input. Overall, the intra-locus balances were 
81.8% (D21S2055) - 96.9% (D16S539), the intra-dye balances 71.9% (TAMRA) – 82.6% (JOE), and the inter-dye 
balances >43%. These figures are consistent with the recommended levels that are >70% for intra-locus balance, 
50% for intra-dye balance, and >30% for inter-dye balance32. The peak imbalances of the D21S2055 became less 
than 50% when the size difference between heterozygous alleles was more than ten repeats (40 nt) (Fig. 2). The 
peak balances further decreased to <45% when the size difference became >50 nt (>12 repeats). For example, an 
average of 43.5% for the genotypes (16.1, 34) (two samples), and 31.8% for the genotype (16.1, 36) (one sample) 
(Fig. 2). This locus is the longest marker in this kit (332 bp to 420 bp) and has the highest number of possible 
alleles (23 alleles: 16.1 to 38).
For the precision study, the data of 22,975 alleles (23,000 alleles from 500 samples excluding 25 alleles with 
a single observation) were used to calculate the standard deviation (s.d.) of the fragment sizes of each allele at a 
locus. Overall, the maximum s.d. was 0.1048 nucleotide (nt) observed in allele 21 at D7S3048 and the minimum 
was 0.0071 nt observed in allele 22 at D3S1744 (Fig. 3). To measure the accuracy of the kit, the average sizes of 
each allele in the data of the 500 samples and in 21 allelic ladders  were compared to the actual size values of the 
corresponding allele (actual sizes provided by the manufacturer). All alleles fell within the range of ±0.41 nt, 
where allele 17 at D6S474 (0.4096 nt) and allele 26 at D7S3048 (−0.4084 nt) recorded the highest difference com-
paring to the actual sizes (Fig. 4). The precision and the accuracy tests demonstrated the capability of detecting 
heterozygous alleles that differ by a single nucleotide and demonstrate that it is unlikely for any allele to be sized 
Figure 2. Peak balance ratios study for the D21S2055 locus. This figure shows a study of the correlation 
between the size differences between heterozygous alleles and the peak balance ratio for the D21S2055 locus 
using data of 500 samples. The peak ratios of all genotypes that have the same size difference (nt) (e.g. the 
genotypes 13, 17; 14, 18; and 15, 19 have the same size difference of 4 nt) were averaged and are represented 
by the black dots. The blue line shows the smoothed mean of the peak ratios. Heterozygote alleles with >50 
nucleotides differences showed peak ratios <45%.
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out of the designated window (±0.5 nt). The SureID 23comp was reliably able to detect genotypes where the dif-
ference between the alleles was a single nucleotide, for example (11.3, 12) at D2S441, (15.3, 16) and (16.3, 17) at 
D1S1656 (100% concordant with GlobalFiler genotypes).
Figure 3. Precision study of the SureID 23comp Kit. The figure shows standard deviation (s.d) values of the 
fragment sizes of 22,981 alleles generated from 500 samples tested by the SureID 23comp. The highest s.d. was 
observed in allele 21 at D7S3048 (0.1048 nt).
Figure 4. Accuracy study of the SureID 23comp Kit. The average of the size values of each allele in the data of 
the 500 samples and in 21 allelic ladders were compared to the actual sizes of the corresponding allele (actual 
sizes provided by the manufacturer). The size differences per nucleotides were calculated and are represented 
by the coloured dots. All alleles fell within the range of ±0.41 nt of the allelic widow; the largest differences were 
seen at D6S474 allele 17 (0.4096 nt) and D7S3048 allele 26 (−0.4084 nt).
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Stutter artefacts are common to all PCR-based STR analysis and the most common type of stutter is a peak 
with one repeat smaller than the true allele34. In this study, the average of the stutter peak ratios was 9.18% and the 
range was from 3.8% for D2S441 to 16.15% for D12S391 (Fig. S4).
This kit provides an allelic ladder representing 232 alleles that are supported by 53 additional bins for variant 
alleles (Fig. S5). After analysing the 500 samples, 34 alleles in 15 loci were not represented by the allelic lad-
der, three of which had been observed ≥40 times (Table 2). In addition, ten of these alleles were situated outside 
the designated widow of their loci: alleles 7 and 8 at D1S1656, 26.3 and 27.3 at D13S325, allele 16 at D4S2366, 
allele 12 at D3S1744, allele 30 at D7S3048, allele 10 at D6S474 and alleles 6 and 7 at D15S659 (Fig. 5a–g). One 
allele (7 at D1S1656) was situated under the designated area of D18S1364 locus (Fig. 5a). Although this allele 
could, in principle, belong to D18S1364 forming triplet allele genotype, it was confirmed by sequencing that it 
belongs to D1S165635. It is not necessary for an allelic ladder to represent all rare alleles, however, alleles out-
side the designated window of a locus may be misinterpreted especially when adjacent loci are homozygous. 
Examining data of 256 samples collected from the population of Ningbo, China (data provided by the Health 
Gene Technologies) (Table 2), most alleles present in the Saudi Arabian population but not present in the allelic 
ladder were absent in the Ningbo population.
The concordance study was also carried out by comparing data of the 500 samples obtained from this study 
and that generated using the GlobalFiler kit26. The five common loci (D1S1656, D2S441, D10S1248, D12S391 
and D16S539) showed 100% concordance. In addition, alleles generated from the bone samples using the SureID 
23comp Kit at the common loci were concordant with alleles generated using the other kits. In addition, the 
amelogenin showed concordant genotypes to those generated by the GlobalFiler kit.
Population study. Assuming independence, the combined match probability (CMP) for the 22 STRs was 
7.4 × 10−27, and the combined power of exclusion (CPE) was 0.999998692. D21S2055 was the most informative 
locus with a match probability (MP) of 0.016, and D17S1301 was the least informative locus with a MP of 0.162. 
Heterozygosity ranged from 0.624 (D20S482) to 0.89 (D21S2055). The number of observed alleles per locus 
varied from 7 alleles in D17S1301 to 20 alleles in D21S2055. Three alleles, allele 14 in D20S482, allele 12 in 
D17S1301 and allele 12 in D9S1122; showed very high frequencies of 0.477, 0.450 and 0.405 respectively. The fre-
quency of the theoretical most common SureID DNA profile, generated based on the frequencies of the 22 STRs 
(and assuming heterozygosity) was 3 × 10−21 that equates to 1 in 3.3 × 1020 (Table S4). The CMP of the 22 STRs 
(7.4 × 10−27) is greater than CMP calculated when using the 21 loci of GlobalFiler kit (1.421 × 10−26)26. Apart of 
SE33, the SureID 23comp Kit includes the four most informative loci that have been studied for the population 
of Saudi Arabia (D21S2055, D12S391, D7S3048, and D1S1656), two of which are included in the GlobalFiler kit 
(Table S4). Data of the 17 non-CODIS loci was merged to the data of 21 loci (total 38 loci) and was statistically 
evaluated for the population of Saudi Arabia. Assuming independence, the 38 loci combined provided 1.7 × 10−46 
CMP, and 0.999999999934248 CPE, and the theoretically most common DNA profile (assuming heterozygosity 
at all loci) was 2.7 × 10−36, which equates to 1 in 3.7 × 1035 (Table S4).
STRs Allele
frequency
STRs Allele
frequency
Saudi Ningbo Saudi Ningbo
D18S1364 11 0.001 0.002 D13S325 26.3 0.002 0
D1S1656 7 0.001 0 27.3 0.001 0
8 0.001 0 D8S1132 13.1 0.001 0
10 0.004 0.001 15 0.003 0
14.3 0.002 0 D7S3048 30 0.001 0
15.3 0.040 0 D2S441 8.3 0.001 0
16.3 0.061 0.007 9 0.005 0
18 0.003 0.011 11.3 0.066 0
19.3 0.006 0.003 13.3 0.001 0
20.3 0.001 0.002 D19S253 6 0.004 0
D9S1122 7 0.001 0 16 0.001 0
D4S2366 16 0.002 0 D22GATA198B05 11.2 0.001 0
D3S1744 12 0.001 0 12 0.004 0
D12S391 18.3 0.005 0 D6S474 10 0.001 0
19.1 0.001 0 D14S1434 16 0.004 0.004
19.3 0.004 0 D15S659 6 0.001 0
27 0.003 0.003 7 0.003 0
Table 2. Alleles not represented by the allelic ladder of SureID 23comp Kit detected in the population of Saudi 
Arabia. Thirty-four alleles were detected at 15 STRs that are not represented by the allelic ladder of the kit. It 
shows also the frequency of these alleles in Ningbo population (data provided by the Health Gene Technologies) 
and in the population of Saudi Arabia. The frequencies of detected alleles in the population of Saudi Arabia 
ranged from 0.001 (one observation) to 0.066 (66 observations).
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The 22 loci were in HWE (P-value > 0.05) except D20S482 which showed significant deviation (P-value = 0). 
For the Saudi population, therefore, this locus should not be included in the product rule to calculate the proba-
bility of a DNA profile.
The data of the 22 loci of the SureID 23comp was uploaded to the R studio to find out the maximum number 
of matched loci between any two DNA profiles using the DNA Tools package. In the 500 samples, the maximum 
number of loci matching between any two samples was 9 out of 22 loci (40% of the 22 loci), which was observed 
in two sample pairs. One pair of profiles showed partial matching (i.e. one of the two alleles) at 20 out of 22 loci. 
This illustrates the power of the additional loci for human identification and kinship testing (Table S5).
To assess the SureID 23comp for kinship testing based on the typical paternity index, the combined typical 
paternity index (CPI) was used to calculate the paternity probabilities with different prior probabilities (Pr): 
0.90, 0.50 and 0.10. Assuming that all loci are independent, the probabilities of paternity were 99.99999988% 
(Pr = 0.90), 99.99999893% (Pr = 0.50) and 99.99999041% (Pr = 0.10), which are higher than those probabili-
ties calculated when using the GlobalFiler kit (Table S6). Under the same assumptions, the 38 loci increased 
the probabilities of paternity to 99,9999999999999972% (Pr = 0.90), 99,9999999999999750% (Pr = 0.50) and to 
99,9999999999997750% (Pr = 0.10) (Table S6).
The ForenSeq DNA Signature Prep (Verogen), when combining the 94 SNPs and the 27 STRs, has shown 
much higher CMP of 10−67–10−69 (length-based STRs calls) and of (1071–10−74) (sequence-based STRs calls), 
where the CMP of the 94 SNPs alone were (10−38–10−35)36. In addition, using MPS systems in kinship testing 
could help in tracking mismatches between tested individuals that have occurred due to mutation in the binding 
sites of primers15. However, this requires additional technology to be implement and is currently not available in 
many countries.
Five loci included in the SureID 23comp (D18S1364, D4S2366, D3S1744, D20S482, and D17S1301) were 
designed to have amplicons <200 bp facilitating characterisation of partial degraded samples. In addition, the 
primer pairs of the D2S441 and D10S1248 mini-STRs, in the SureID 23comp Kit, were designed to generate 
longer amplicons (310–446 bp) than primer pairs used in the GlobalFiler kit (<125 bp), which enabled more 
space for other mini-STRs, e. g. D17S1301 and D4S2366 (<150 bp) in the SureID 23comp. As a result, combin-
ing both kits will increase the number of STRs <200 bp to 12 STRs and thus increases the CMP to 7.9 × 10−14 
(Table S7).
Figure 5. Alleles outside the allelic ladder windows of the SureID 23comp Kit. This figure shows ten alleles 
observed in the population of Saudi Arabia that are not represented in the allelic ladder and were situated 
outside the designated widow of their loci: (a) Alleles 7 and 8 at D1S1656; (b) Alleles 26.3 and 27.3 at D13S325; 
(c) Allele 30 at D7S3048; (d) Allele 16 at D4S2366; (e) Allele 12 at D3S1744; (f) Allele 10 at D6S474; (g) Alleles 6 
and 7 at D15S659. Allele 7 at D1S1656 (a) was situated under the designated area of D18S1364 locus.
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LD and RF study. Family studies have previously been carried out to estimate recombination fraction (RF) 
for four syntenic loci residing on the same chromosome’s arm vWA-D12S391, D5S818-CSF1PO, TPOX-D2S441 
and D21S11-PentaD typed when using any of the commonly used STR kits21–23. RF values were 0.1721, 0.1322, and 
0.1123 for vWA-D12S391; 0.19737 for D5S818-CSF1PO; 0.5321 for TPOX-D2S441 and 0.31637 D21S11-PentaD. The 
Chr. Syntenic Pair
LD test
P-value
HapMap proxy 
SNP position 
(GRCh37)b
Cumulative 
genetic map 
distance in cMb
Genetic map 
distance in 
cM
RFs from 
Kosambi 
mapping 
functiona–c
RFs estimated 
based on 
family 
studiesd–f
Chr.2 TPOX 0.97764 1493487 1.6661 88.8129 0.4721a 0.53d
D2S441 68239020 90.47903
Chr.2(p-q) D2S1338 0.99164 218879435 223.4832 133.0042 0.4951c 0.58d
D2S441 68239020 90.47903
Chr.2(p-q) TPOX 0.79338 1493487 1.6661 221.8171 0.4999c 0.51d
D2S1338 218879435 223.4832
Chr.3(p-q) D3S1358 0.99193 45582627 67.1789 90.0624 0.4735a 0.64d
D3S1744 147092143 157.24131
Chr.4(p-q) FGA 0.99771 155508100 156.81293 143.8662 0.4968c 0.51d
D4S2366 6484806 12.9467
Chr.5 D5S2800 0.15198 58698677 70.3208 56.3520 0.4050b N/A
D5S818 123111652 126.67284
Chr.5 D5S2800 0.85646 58698677 70.3208 84.1132 0.4666c N/A
CSF1PO 149455757 154.43395
Chr.5 D5S818 0.69008 123111652 126.67284 27.7611 0.2522a 0.18d
CSF1PO 149455757 154.43395
Chr.6 SE33 0.99963 88986609 95.44921 23.2133 0.2168a 0.19d
D6S474 112879893 118.66248
Chr.7(p-q) D7S3048 0.98684 21266723 36.14071 64.0605 0.4284b 0.4997e
D7S820 83789257 100.2012
Chr.8 D8S1132 0.23577 107330479 119.96228 16.4809 0.1591a 0.1443e
D8S1179 125907927 136.44313
Chr.11 TH01 0.20421 2192166 4.48933 28.3996 0.2569b 0.2152e
D11S2368 19281171 32.88891
Chr.12 vWA 0.89307 6093924 15.63031 11.9410 0.1172a 0.1259e
D12S391 12450501 27.57129
Chr.13 D13S325 0.97422 43173444 44.90825 34.9225 0.3016b 0.2533e
D13S317 82721723 79.83074
Chr.18 D18S51 0.04312 60949983 88.92051 2.2970 0.0229b 0.0327e
D18S1364 63400151 91.21746
Chr.19(p-q) D19S433 0.78742 30417603 51.72618 12.4538 0.1228b 0.1101f
D19S253 15728103 39.27234
Chr.21 D21S11 1 20554558 14.64555 34.8192 0.3010a 0.32d
D21S2055 41191871 49.46478
Chr.22 D22S1045 0.98893 37535663 46.21362 38.8178 0.3253b N/A
D22GATA198B05 17651831 7.39585
Chr.15* Penta E — 97377441 124.05054 74.5331 0.4517b N/A
D15S659 46371620 49.51748
Chr.21* Penta D — 45056178 59.37591 9.9111 0.0978b N/A
D21S2055 41191871 49.46478
Table 3. LD test results for 18 pairs of syntenic loci formed when combining loci included in the SureID 
23comp and GlobalFiler kits. This test was performed for data generated from the 500 samples from 
Saudi population for the 38 loci. No significant deviation from linkage equilibrium (LE) was detected (P-
value = 0.003). RFs that previously derived from HapMap data and from family studies were reviewed from 
literature4,12,21,22,24. RFs derived from HapMap data for D2S1338-D2S441, TPOX-D2S1338, FGA-D4S2366 and 
D5S2800-CSF1PO pairs, were calculated based on cumulative genetic map distance provided in Phillips12 and 
using Excel tool developed by Phillips et al.4. aData reviewed from Phillips et al.4. bData reviewed from Phillips12. 
cRFs were calculated based on cumulative genetic map distance provided in Phillips12 and using an excel 
tool developed by Phillips et al.4. dData reviewed from Westen et al.21. eData reviewed from Liu et al.22. fData 
reviewed from Wu et al.24. *Potential syntenic pairs when combining the SureID 23comp with kits that include 
the Penta E and Penta D loci (LD was not tested). N/A: No data available from family studies.
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high-density multi-point SNP data of HapMap was also used to approximate the genetic distance between these 
syntenic loci and gave RF values of 0.12 for vWA-D12S391, 0.25 for D5S818-CSF1PO, 0.36 for D21S11-PentaD, 
and of 0.47 for TPOX-D2S4414; these values are similar to those generated using family studies.
It was concluded that, for most pedigrees, the RF value of ~0.12 has almost zero effect in any population as 
long as no linkage disequilibrium was detected38. For some pedigrees, where at least one individual has a hete-
rozygote genotype in the both syntenic loci and is involved in at least two transmissions of genetic components, 
linkage can have a significant effect in the product rule calculation in kinship testing38.
However, using the SureID 23comp Kit in conjunction with any of commonly used kits, will increase 
the number of potentially linked syntenic loci located on the same arm to 12–15 pairs (D5S818-D5S2800, 
CSF1PO-D5S2800, SE33-D6S474, D8S1179-D8S1132, TH01-D11S2368, D13S317-D13S325, Penta E-D15S659, 
D18S51-D18S1364, D21S2055-D21S11, D21S2055-Penta D, D22S1045- D22GATA198B05, vWA-D12S391, 
D5S818-CSF1PO, TPOX-D2S441 and D21S11-PentaD).
The potential linkage between 18 syntenic loci (12 on the same arm and 6 on different arms), which resulted 
from combining the 38 STRs, were tested using the likelihood ratio test (because the gamatic phase of the geno-
types is unknown)29. Although, significant departure from HWE could invalidate the test, none of the 18 pairs is 
on chromosome 20 and thus the significant departure of D20S482 from HWE is not relevant. After Bonferroni 
correction (P-value = 0.003), no significant deviation from linkage equilibrium (LE) was detected between any of 
the 18 syntenic loci (Table 3).
Table 3 also reviews RFs that previously derived from HapMap data and from family studies4,12,21,22,24. 
In addition, RFs derived from HapMap data for D2S1338-D2S441, TPOX-D2S1338, FGA-D4S2366 and 
D5S2800-CSF1PO pairs, were calculated based on cumulative genetic map distance provided in Phillips12 and 
using the Excel tool developed by Phillips et al.4.
The genetic distance (cM) estimated based on the HapMap data ranged from 3.49 cM for D18S51-D18S1364 
pair to 226.5 cM for TPOX-D2S1338 pair. Apart from the D18S51-D18S1364 and PentaD-D21S2055 pairs, all 
potential linked loci showed RF values > 0.12 and thus they can be included in the product rule calculation for 
kinship testing for most pedigrees. For pairs showing RF values <0.12, excluding the less informative locus from 
the probability estimation23, which is the D18S1364 for the Saudi population, is an option. However, due to con-
cerns that this may lead to an overestimation or to an underestimation of the strength of an evidence, Gill et al.38 
illustrated a methodology by which the RFs can be included in the probability estimation.
Conclusion
The SureID 23comp was validated following the minimum criteria for validation recommended by the ENFSI 
and the SWGDAM for forensic applications as a supplementary STR kit. The kit is reproducible, precise, accurate 
and reliable for forensic application as a supplementary kit and for databasing. The identity of the D5 locus was 
confirmed and has now been updated by the manufacturer to D5S2800.
The sensitivity tests demonstrate the capability of generating a full profile below the recommended DNA input 
but showed that the kit was less sensitive compared to other commonly with degraded samples, which was at least 
in part because of the lower volume of template that can be added. Therefore, increasing the concentration of the 
reaction mix will allow more space for DNA input to 15 µl rather than 6.25 µl, which will increase the sensitivity 
of the kit.
Including additional alleles and allele variations in the available spaces of the allelic ladder will allow specific 
allele designation and will minimise the need to re-run undesignated alleles. In addition, caution should be taken 
when using the kit with potentially degraded samples (e.g. DVI cases) due to the peak imbalance of D21S2055.
For kinship testing, typically, the kit achieved a CPI of 93835307.21 that is two times higher the CPI 
recorded for the GlobalFiler kit and allowed higher paternity probabilities 99.99999988%, 99.99999893% and 
99.99999041% in different prior probabilities, demonstrating the informativeness of the STRs included in the 
kit. In addition, utilising the 38 loci will increase the certainty of the paternity probabilities, using different prior 
probabilities, to 99,9999999999999972%, 99,9999999999999750% and to 99,9999999999997750%, which is useful 
for complex cases. However, caution should be considered when estimating likelihoods if the D18S51-D18S1364 
and/or PentaD-D21S2055 pairs are included.
Overall, this study evaluates the utility of the SureID 23comp as a supplementary kit for kinship testing and 
determined that the kit met the criteria commonly used in forensic genetics laboratories. The kit allows the anal-
ysis of 17 non-CODIS loci and increases likelihood ratios, and thereby has the potential to increase the level of 
confidence in conclusions in complex kinship tests using already established technology.
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